期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

miRNAs慢病毒文库筛选靶向EZH23'非翻译区的新型miRNAs及其在乳腺癌中的表达 被引量：2

Screening of novel miRNAs targeting EZH2 3' untranslated region using lenti-miR viruslibrary and their expressions in breast cancer cells and tissues
暂未订购
导出
摘要 目的重组过表达EZH2基因3'非翻译区的MCF-7细胞株中筛选靶向miRNAs,并进行细胞和组织定量分析。方法重组细胞株感染慢病毒文库,利用细胞毒性药物筛选后抽提细胞基因组,以此为模板PCR扩增出miRNA前体,测序确定miRNAs名称,并对其进行PCR定量分析。结果在重组细胞株中共筛选出7种miRNAs,依次为miR-15b、miR-16-2、miR-181b2、miR-217、miR-224、miR-329-1、miR-487b,这些新型miRNAs用生物信息学软件PicTar和TargetScan无法预测。Real-time PCR发现,与乳腺癌细胞MCF-7相比,正常乳腺细胞株HBL-100中miR-217、miR-329-1、miR-487b高表达;乳腺癌组织中仅miR-15b及miR-16-2表达增加,与癌旁组织相比差异有统计学意义(P<0.05)。结论在重组过表达EZH2 3'-UTR的乳腺癌MCF-7细胞株中结合慢病毒文库可筛选出用生物信息学软件未预测的新型靶向miRNAs,这些新型miRNA在正常乳腺细胞与肿瘤细胞及组织中存在差异表达。 Objective To screen novel miRNAs targeting EZH2 3＆#39; untranslated region （UTR） in recombinational MCF-7 breast cancer cells over-expressing EZH2 3＆#39; UTR and quantitative analyze the expressions of the screened miRNA in breast cancer cells and tissues. Methods A lentiviral library was transfected into the recombinant cell line MCF-7. The cells were screened with cytotoxic agents before extraction of the genome for amplification of the miRNA precursors using PCR. The screened miRNAs were identified with sequence analysis and their expressions were analyzed quantitatively with real-time PCR in breast cancer cells and tissues. Results Seven miRNAs were screened from the recombinant MCF-7 cells, namely miR-15b, miR-16-2, miR-181b2, miR-217, miR-224, miR-329-1, and miR-487b, all of which failed to be predicted by bioinformatics software. Real-time PCR showed that miR-217, miR-329-1, and miR-487b were over-expressed in MCF-7 cells, and the expression of miR-15b and miR-16-2 was significantly increased in cancer tissues compared with the adjacent tissues （P＆lt;0.05）. Conclusions Novel targeted miRNAs that can not be predicted by bioinformatics software were successfully screened from MCF-7 breast cancer cells over-expressing EZH2 3＆#39; UTR. These miRNAs are expressed differentially between normal breast cells and breast cancer tissues.
作者 刘萃萃 王璐璐 赵卫卫 彭攸 王玉平 孙振亮 冯景
机构地区 南方医科大学第三临床医学院 南方医科大学附属奉贤医院检验科
出处 《南方医科大学学报》 CAS CSCD 北大核心 2014年第3期368-372,共5页 Journal of Southern Medical University
基金 国家自然科学基金(81202104) 上海市自然科学科学基金面上项目(12ZR1426300) 上海市卫生系统优秀学科带头人培养计划(XBR20130114)~~
关键词 乳腺癌 EZH2 慢病毒文库 EZH2 3＆#39 UTR miRNA breast carcinoma 3＆#39 untranslated region microRNA lenti-miR virus library
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献1

二级参考文献18

  • 1Weikert S, Christoph F, K-llermann J, et al. Expres- sion levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas [ J ]. Int J Mol Med, 2005,16(2) :349-353.
  • 2Yoon KA, Gil H J, Han J, et al. Genetic polymor- phisms in the polycomb group gene EZH2 and the risk of lung cancer[J]. J Whorac Oncol,2010,5( 1 ) : 10-16.
  • 3Holm K, Grabau D, Ltivgren K, et al. Global H3K27 trimethylation and E2H2 abundance in breast tumor subtypes [ J ]. Mol Oncol, 2012,6 ( 5 ) : 494- 506.
  • 4Yoo KH, Hennighausen L. EZH2 methyhransferase and H3K27 methylation in breast cancer[J]. Int J Biol Sci ,2012,8( 1 ) :59-65.
  • 5Gong Y, Huo L, Liu P, et al. Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome [J]. Cancer, 2011,117 (24) :5476-5484.
  • 6Varambally S, Dhanasekaran SM, Zhou M, et al. The polycomb group protein EZH2 is involved in progres- sion of prostate cancer [J]. Nature, 2002, 419 (6907) :624-629.
  • 7He LR, Liu MZ, Li BK, et al. High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradio- therapy [ J]. Int J Cancer ,2010,127 ( 1 ) : 138-147.
  • 8S.ander S, Bullinger L, Klapproth K, et al. MYC stimulates EZH2 expression by repression of its nega- tive regulator miR-26a [ J ]. Blood, 2008,112 ( 10 ) : 4202-4212.
  • 9Bao B, Ali S, Banerjee S, et al . Cureumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expres- sion[J]. Cancer Res,2012,72( 1 ) :335-345.
  • 10Gong Y, Huo L, Liu P, et al. Polycomb group protein EZH2 is frequently expressed in inflammatorybreast cancer and is predictive of worse clinical out- come [ J ]. Cancer, 2011,117 (24) : 5476-5484.

同被引文献17

  • 1Hofman J, Skarka A, Havrankova J, et al. Pharmacokinetic interactions of breast cancer chemotherapeutics with human doxorubicin reductases [J]. Biochem Pharmacol, 2015, 96(3) 168-178.
  • 2Kim KY, Kim SH, Yu SN, et al. Salinomycin enhances doxo- rubicin induced cytotoxicity in multidrug resistant MCF-7/ MDR human breast cancer cells via decreased efflux of doxoru- bicin [J]. Mol MedRep, 2015, 12(2) :1898-1904.
  • 3Lv J, Xia K, Xu P, et al. miRNA expression patterns in che- moresistant breast cancer tissues [J]. Biomed Pharmacother, 2014, 68(8) :935-942.
  • 4Achari C, Winslow S, Ceder Y, et al. Expression of miR-34c induces G2/M cell cycle arrest in breast cancer ceils [ [J]. BMC Cancer, 2014, 26(14): 538.
  • 5Navarro F, Lieberman J. miR-34 and p53: New Insights into a Complex Functional Relationship [J]. PLoS One, 2015, 10 (7) :e0132767.
  • 6Xiang S, Dauchy RT, Hauch A, et al. Doxorubicin resistance in breast cancer is driven by light at night induced disruption of the circadian melatonin signal [J]. J Pineal Res, 2015, 59 (1) 60-69.
  • 7Gezer U, Keskin S, I ci A, et al. Abundant circulating mi- croRNAs in breast cancer patients fluctuate considerably during neoadjuvant chemotherapy[J]. Oncol Lett, 2014, 8 (2) : 845- 848.
  • 8Medimegh I, Omrane I, Privat M, et al. MicroRNAs expres-sion in triple negative vs non triple negative breast cancer in Tunisia.. interaction with clinical outcome [J]. PLoS One, 2014, 9(11):e111877.
  • 9Li R, Shi X, Ling F, et al. MiR 34a suppresses ovarian cancer proliferation and motility by targeting AXL[J]. Tumour Biol, 2015, 36(9):7277- 7283.
  • 10Stahlhut C, Slack FJ. Combinatorial Action of MicroRNAs let- 7 and miR-34 Effectively Synergizes with Erlotinib to Suppress Non-small Cell Lung Cancer Cell Proliferation[J]. Cell Cycle, 2015, 14(13) :2171-2180.

引证文献2

二级引证文献3

南方医科大学学报
2014年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部